Subscribe
Log In More

Log in via Institution
Log in via OpenAthens
Log in via AFMR

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Current issue

Archive

Authors

About
Subscribe
Log in More

Log in via Institution
Log in via OpenAthens
Log in via AFMR

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

glucagon-like peptide 1

Obesity and GLP-1 RAs
Tamis Bright

Journal of Investigative Medicine Jan 2022, 70 (1) 1-2; DOI: 10.1136/jim-2021-002268
Semaglutide 2.4 mg: the latest GLP-1RA approved for obesity
Ricardo Villela, Ricardo Correa

Journal of Investigative Medicine Jan 2022, 70 (1) 3-4; DOI: 10.1136/jim-2021-002227
Wegovy (semaglutide): a new weight loss drug for chronic weight management
Gurdeep Singh, Matthew Krauthamer, Meghan Bjalme-Evans

Journal of Investigative Medicine Jan 2022, 70 (1) 5-13; DOI: 10.1136/jim-2021-001952